Transgene Biotek Ltd (TRBL)

BSE
Currency in INR
4.25
+0.01(+0.24%)
Closed·
TRBL Scorecard
Full Analysis
May have trouble making interest payments on debt
TRBL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.174.30
52 wk Range
3.2210.84
Key Statistics
Edit
Bid/Ask
4.20 / 4.25
Prev. Close
4.24
Open
4.3
Day's Range
4.17-4.3
52 wk Range
3.22-10.84
Volume
5.56K
Average Volume (3m)
27.42K
1-Year Change
-52.67%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TRBL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Transgene Biotek Ltd News & Analysis

Show more

Transgene Biotek Company Profile

Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India. It offers oncology drugs, oral drug delivery, and biogenerics, as well as HIV and multiple sclerosis drugs. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption. The company was incorporated in 1990 and is based in Sangareddy, India.

Compare TRBL to Peers and Sector

Metrics to compare
TRBL
Peers
Sector
Relationship
P/E Ratio
−47.6x32.6x−0.4x
PEG Ratio
-0.220.00
Price/Book
3.2x3.7x2.6x
Price / LTM Sales
123.5x6.1x3.1x
Upside (Analyst Target)
-26.3%51.1%
Fair Value Upside
Unlock−10.1%8.9%Unlock

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-0.11 / --
Revenue / Forecast
-5,430,000.00 / --
EPS Revisions
Last 90 days

TRBL Income Statement

FAQ

What Is the Transgene Biotek (TRBL) Stock Price Today?

The Transgene Biotek stock price today is 4.25.

What Stock Exchange Does Transgene Biotek Trade On?

Transgene Biotek is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Transgene Biotek?

The stock symbol for Transgene Biotek is "TRBL."

What Is the Transgene Biotek Market Cap?

As of today, Transgene Biotek market cap is 322.02M.

What Is Transgene Biotek's Earnings Per Share (TTM)?

The Transgene Biotek EPS (TTM) is -0.09.

From a Technical Analysis Perspective, Is TRBL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Transgene Biotek Stock Split?

Transgene Biotek has split 0 times.

How Many Employees Does Transgene Biotek Have?

Transgene Biotek has 0 employees.

What is the current trading status of Transgene Biotek (TRBL)?

As of 14 Jun 2025, Transgene Biotek (TRBL) is trading at a price of 4.25, with a previous close of 4.24. The stock has fluctuated within a day range of 4.17 to 4.30, while its 52-week range spans from 3.22 to 10.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.